MDM2 regulates dihydrofolate reductase activity through monoubiquitination.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-07-5271PMID 18451149PMCID PMC3536468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a bifunctional catalase-peroxidase of Burkholderia cenocepacia.

  2007cited by this paper
• Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity

  2007cited by this paper
• Molecular basis of antifolate resistance

  2007cited by this paper
• The RING finger domain of MDM2 is essential for MDM2-mediated TGF-beta resistance.

  2007cited by this paper
• Translesion synthesis in mammalian cells.

  2006cited by this paper
• Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

  2006cited by this paper
• Dietary folate is associated with p16INK4A methylation in head and neck squamous cell carcinoma

  2006cited by this paper
• MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

  2005cited by this paper
• Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation

  2005cited by this paper
• Regulation of p53 and MDM2 Activity by MTBP

  2005cited by this paper
• Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

  2004cited by this paper
• Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues.

  2004cited by this paper
• p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53

  2004cited by this paper
• DNA Methylation, Cancer Susceptibility, and Nutrient Interactions

  2004cited by this paper
• DNA methylation and cancer.

  2004cited by this paper
• p53-independent functions of MDM2.

  2003cited by this paper
• MDM2, an introduction.

  2003cited by this paper
• Stimulation of human DNA polymerase ϵ by MDM2

  2003cited by this paper
• Stimulation of human DNA polymerase epsilon by MDM2.

  2003cited by this paper
• MDM2 Promotes Ubiquitination and Degradation of MDMX

  2003cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

  2002cited by this paper
• Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.

  2002cited by this paper
• Expression of the Murine Double Minute Gene 2 Oncoprotein in Esophageal Squamous Cell Carcinoma as a Novel Marker for Lack of Response to Chemoradiotreatment

  2002cited by this paper
• Ubiquitin and proteasomes: Protein regulation by monoubiquitin

  2001cited by this paper
• Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin

  2001cited by this paper
• Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.

  2000cited by this paper
• mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.

  2000cited by this paper
• Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53*

  2000cited by this paper
• A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2*

  2000cited by this paper
• MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon.

  2000cited by this paper
• 5-Azacytidine Induces Transgene Silencing by DNA Methylation in Chinese Hamster Cells

  1999cited by this paper
• Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.

  1999cited by this paper
• The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell‐cycle‐inhibitory function induces tumorigenesis

  1998cited by this paper
• Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.

  1998cited by this paper
• The Mdm2 Oncoprotein Interacts with the Cell Fate Regulator Numb

  1998cited by this paper
• p53-Independent Role of MDM2 in TGF-β1 Resistance

  1998cited by this paper
• p53-independent role of MDM2 in TGF-beta1 resistance.

  1998cited by this paper
• Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer

  1996cited by this paper
• The MDM2 Oncoprotein Binds Specifically to RNA through its RING Finger Domain

  1996cited by this paper
• Interaction between the retinoblastoma protein and the oncoprotein MDM2

  1995cited by this paper
• Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein

  1995cited by this paper
• Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

  1983cited by this paper
• Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts.

  1981cited by this paper
• Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells.

  1978cited by this paper
• Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line.

  1978cited by this paper
• Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases.

  1976cited by this paper

• The Role of Nuclear Phosphoinositides in the p53-MDM2 Nexus

  2025cites this paper
• Urinary metabolite model to predict the dying process in lung cancer patients

  2025cites this paper
• Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways

  2025cites this paper
• Cycling back to folate metabolism in cancer

  2024cites this paper
• Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment

  2024cites this paper
• MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors

  2023cites this paper
• Regulatory mechanisms of one-carbon metabolism enzymes

  2023cites this paper
• Network targeting combination therapy of synthetic lethal vulnerabilities in 9p21-deficient glioblastoma: A case report

  2023cites this paper
• Drug repositioning for esophageal squamous cell carcinoma

  2022cites this paper
• The p53 Pathway and Metabolism: The Tree That Hides the Forest

  2021cites this paper
• TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies

  2020cites this paper
• Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy †

  2020cites this paper
• Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma

  2020cites this paper
• Targeting MDM2 for novel molecular therapy: Beyond oncology

  2020cites this paper
• Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

  2019cites this paper
• Human dihydrofolate reductase is a substrate of protein kinase CK2α.

  2019cites this paper
• ДИСБАЛАНС КОЛИЧЕСТВЕННОГО СООТНОШЕНИЯ НУКЛЕОТИДОВ ПРИ ОВЕРЭКСПРЕССИИ УБИКВИТИНЛИГАЗЫ MDM2 В КЛЕТОЧНОЙ МОДЕЛИ КАРЦИНОМЫ МОЛОЧНОЙ ЖЕЛЕЗЫ ЧЕЛОВЕКА, "Цитология"

  2018cites this paper
• Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.

  2018cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• The roles of actin cytoskeleton and actin-associated protein Crn1p in trap formation of Arthrobotrys oligospora.

  2017cites this paper
• Structural Exploration and Conformational Transitions in MDM2 upon DHFR Interaction from Homo sapiens: A Computational Outlook for Malignancy via Epigenetic Disruption

  2016influential citation
• Loss of Diacylglycerol Kinase-Ζ Inhibits Cell Proliferation and Survival in Human Gliomas

  2016cites this paper
• Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo

  2016cites this paper
• Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.

  2016cites this paper
• The viral non-structural protein 1 alpha (Nsp1α) inhibits p53 apoptosis activity by increasing murine double minute 2 (mdm2) expression in porcine reproductive and respiratory syndrome virus (PRRSV) early-infected cells.

  2016cites this paper
• L'oncogène Mdm2 : nouvelles fonctions et implications dans le métabolisme des cellules cancéreuses

  2016cites this paper
• The interplay between MDM2 and PSMA in metastatic breast cancer cells

  2016cites this paper
• The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers.

  2015cites this paper
• A novel role for the alcohol sensitive ring/PHD finger protein Asr1p in regulating cell cycle mediated by septin-dependent assembly in yeast.

  2015cites this paper
• A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity

  2015cites this paper
• Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.

  2014cites this paper
• MDM2’s social network

  2014cites this paper
• MDM2 Mediates Nonproteolytic Polyubiquitylation of the DEAD-Box RNA Helicase DDX24

  2014cites this paper
• Targeting MDM2-p53 interaction for cancer therapy: are we there yet?

  2014cites this paper
• Diverse Mechanisms of G Protein Regulation by Monoubiquitination

  2013cites this paper
• The MDM 2p 53 pathway revisited

  2013cites this paper
• Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer

  2013cites this paper
• The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer

  2013cites this paper
• The MDM2-p53 pathway revisited

  2013cites this paper
• Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

  2011cites this paper
• The former annotated human pseudogene dihydrofolate reductase-like 1 (DHFRL1) is expressed and functional

  2011cites this paper
• The nucleolus directly regulates p53 export and degradation

  2011cites this paper
• Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus*

  2011cites this paper
• MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.

  2011cites this paper
• MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

  2011cites this paper
• Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.

  2010cites this paper
• Mdm2-mediated ubiquitylation: p53 and beyond

  2010cites this paper
• Will the ubiquitin system furnish as many drug targets as protein kinases?

  2010cites this paper
• Mdm2 links genotoxic stress and metabolism to p53

  2010cites this paper
• MDM2 promotes cell motility and invasiveness through a RING‐finger independent mechanism

  2010cites this paper
• Mdm2 Directs the Ubiquitination of β-Arrestin-sequestered cAMP Phosphodiesterase-4D5*

  2009cites this paper
• The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake

  2009cites this paper
• Murine double minute 2: p53-independent roads lead to genome instability or death.

  2009cites this paper